Conditional ETDT analysis of the Human Leukocyte Antigen region in type 1 diabetes

Several studies have indicated that additional genes in the major histocompatibility complex (MHC) region, other than the class II genes HLA‐DQB1 and ‐DRB1 (the IDDM1 locus), may contribute to susceptibility and resistance to type 1 diabetes. The relative magnitude of these non‐ DR/DQ effects is uncertain and their map location is unknown owing to the extraordinary linkage disequilibrium that extends over the 3.5 Mb of the MHC. The homozygous parent test has been proposed as a method for detection of additional risk factors conditional on HLA‐DQB1 and ‐DRB1. However, this method is inefficient since it uses only parents homozygous for the primary disease locus, the DQB1‐DRB1 haplotype. To overcome this limitation, Conditional ETDT was used in the present report to test for association conditional on the DQB1‐DRB1 haplotype, thereby allowing all parents to be included in the analysis. First, we confirm in UK and Sardinian type 1 diabetic families that allelic variation at HLA‐DRB1 has a very significant effect on the association of DQB1 and vice versa. The Conditional ETDT was then applied to the HLA TNF (tumour necrosis factor) region and microsatellite marker D6S273 region, both of which have been reported to contribute to IDDM1 independent of the HLA‐DQB1‐DRB1 genes. We found no evidence for a major role for either of these two regions in IDDM1.

[1]  J. Todd,et al.  The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. , 1999, American journal of human genetics.

[2]  J. Todd,et al.  From genome to aetiology in a multifactorial disease, type 1 diabetes , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[3]  A. Cambon-Thomsen,et al.  Microsatellites in the HLA region: 1998 update. , 1998, Tissue antigens.

[4]  Amanda J. Wilson,et al.  A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients , 1998, Nature Genetics.

[5]  P. H. Moghaddam,et al.  Genetic Structure of IDDM1: Two Separate Regions in the Major Histocompatibility Complex Contribute to Susceptibility or Protection , 1998, Diabetes.

[6]  F. Schuit,et al.  Genetic structure of IDDM1: two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Belgian Diabetes Registry. , 1998, Diabetes.

[7]  J. Wautier,et al.  Influence of metabolic and genetic factors on tumour necrosis factor-alpha and lymphotoxin-alpha production in insulin-dependent diabetes mellitus. , 1997, Diabetes & Metabolism.

[8]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  H. Rammensee,et al.  HLA-Encoded Genetic Predisposition in IDDM: DR4 Subtypes May Be Associated With Different Degrees of Protection , 1997, Diabetes.

[10]  G. Hitman,et al.  THE EFFECT OF TNF*B GENE POLYMORPHISM ON TNF‐α AND ‐β SECRETION LEVELS IN PATIENTS WITH INSULIN‐DEPENDENT DIABETES MELLITUS AND HEALTHY CONTROLS , 1996 .

[11]  W. Klitz,et al.  The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. , 1996, American journal of human genetics.

[12]  W J Ewens,et al.  The TDT and other family-based tests for linkage disequilibrium and association. , 1996, American journal of human genetics.

[13]  S. Hauser,et al.  Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. , 1996, Human immunology.

[14]  J. She.  Susceptibility to type I diabetes: HLA-DQ and DR revisited. , 1996, Immunology today.

[15]  D. Monos,et al.  Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus. Linkage disequilibrium of TNFab microsatellite alleles with HLA haplotypes. , 1995, Human immunology.

[16]  F. Cucca,et al.  The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci. , 1995, Human immunology.

[17]  D. Curtis,et al.  An extended transmission/disequilibrium test (TDT) for multi‐allele marker loci , 1995, Annals of human genetics.

[18]  S. C. Jenkins,et al.  Chromosome–specific microsatellite sets for fluorescence–based, semi–automated genome mapping , 1994, Nature Genetics.

[19]  F. Pociot,et al.  No independent association between a tumor necrosis factor‐α promotor region polymorphism and insulin‐dependent diabetes mellitus , 1993, European journal of immunology.

[20]  Henry A. Erlich,et al.  HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families , 1993, Nature Genetics.

[21]  D. Chaplin,et al.  Highly informative typing of the human TNF locus using six adjacent polymorphic markers. , 1993, Genomics.

[22]  A. Cambon-Thomsen,et al.  Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF‐a and TNF‐0 by human mononuclear cells: a possible link to insulin‐dependent diabetes mellitus , 1993 .

[23]  A. Cambon-Thomsen,et al.  Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  U. Spengler,et al.  Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF- beta production , 1991, The Journal of experimental medicine.

[25]  H. Mcdevitt,et al.  Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Todd,et al.  Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping , 1989, Nature.

[27]  J. R. Rowe,et al.  A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. , 1989, The Journal of clinical investigation.

[28]  P. A. Peterson,et al.  HLA-D region β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals , 1983, Nature.

[29]  S. Schneider.  Arlequin ver.1.1:a software for population genetic data analysis. , 1997 .

[30]  G. Hitman,et al.  The effect of TNF*B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls. , 1996, European journal of immunogenetics.

[31]  J. Todd,et al.  The British Diabetic Association--Warren repository. , 1990, Autoimmunity.

[32]  A. Svejgaard,et al.  HLA and insulin‐dependent diabetes: An overview , 1989, Genetic epidemiology.

[33]  J. Todd,et al.  HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. , 1987, Nature.